Avalyn Pharma Inc. (AVLN)
NASDAQ: AVLN · Real-Time Price · USD
27.33
+0.40 (1.49%)
At close: May 8, 2026, 4:00 PM EDT
27.45
+0.12 (0.44%)
After-hours: May 8, 2026, 4:19 PM EDT
Avalyn Pharma Market Cap
Avalyn Pharma has a market cap or net worth of $1.14 billion as of May 8, 2026.
Market Cap
1.14B
Enterprise Value
1.01B
1-Year Change
n/a
Ranking
Category
Stock Price
27.33
Market Cap Chart
Since the IPO on April 30, 2026, Avalyn Pharma's market cap has increased from $752.62M to $1.14B, an increase of 51.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.14B | 1.49% |
| May 7, 2026 | 1.13B | -2.81% |
| May 6, 2026 | 1.16B | 1.02% |
| May 5, 2026 | 1.15B | -5.64% |
| May 4, 2026 | 1.22B | -2.58% |
| May 1, 2026 | 1.25B | 65.78% |
| Apr 30, 2026 | 752.62M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maravai LifeSciences Holdings | 1.25B |
| MapLight Therapeutics | 1.24B |
| MoonLake Immunotherapeutics | 1.22B |
| DBV Technologies | 1.19B |
| Zenas BioPharma | 1.17B |
| EyePoint | 1.14B |
| Inventiva | 1.11B |
| Hemab Therapeutics Holdings | 1.11B |